View Item 

Show simple item record

Causes of Preventable Visual Loss in Type 2 Diabetes Mellitus
dc.contributor.authorHayward, Rodney A.en_US
dc.contributor.authorCowan, Claudeen_US
dc.contributor.authorGiri, Vedaen_US
dc.contributor.authorLawrence, Mary G.en_US
dc.contributor.authorMakki, Fatimaen_US
dc.date.accessioned2010-06-01T18:36:22Z
dc.date.available2010-06-01T18:36:22Z
dc.date.issued2005-05en_US
dc.identifier.citationHayward, Rodney A.; Cowan, Claude; Giri, Veda; Lawrence, Mary G.; Makki, Fatima (2005). "Causes of Preventable Visual Loss in Type 2 Diabetes Mellitus." Journal of General Internal Medicine 20(5): 467-469. <http://hdl.handle.net/2027.42/71808>en_US
dc.identifier.issn0884-8734en_US
dc.identifier.issn1525-1497en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71808
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15963174&dopt=citationen_US
dc.format.extent75143 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights© 2005 by the Society of General Internal Medicine. All rights reserveden_US
dc.subject.otherDiabetesen_US
dc.subject.otherQuality of Careen_US
dc.subject.otherQuality Measurement and Monitoringen_US
dc.subject.otherRetinopathyen_US
dc.subject.otherScreeningen_US
dc.titleCauses of Preventable Visual Loss in Type 2 Diabetes Mellitusen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA ;en_US
dc.contributor.affiliationumDepartment of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, MI, USA ;en_US
dc.contributor.affiliationotherVA Center for Practice Management and Outcomes Research, VA Ann Arbor Health Care System, Ann Arbor, MI, USA ;en_US
dc.contributor.affiliationotherOphthalmology Section, Washington DC VA Medical Center, Washington, DC, USA ;en_US
dc.contributor.affiliationotherOphthalmology Section, Minneapolis VA Medical Center, Minneapolis, MN, USA.en_US
dc.identifier.pmid15963174en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71808/1/j.1525-1497.2005.40073.x.pdf
dc.identifier.doi10.1111/j.1525-1497.2005.40073.xen_US
dc.identifier.sourceJournal of General Internal Medicineen_US
dc.identifier.citedreference1.  Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991; 98: 766 – 85.en_US
dc.identifier.citedreferenceJavitt JC, Aiello L. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996; 124: 164 – 9.en_US
dc.identifier.citedreferenceVijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med. 1997; 12: 567 – 80.en_US
dc.identifier.citedreference4.  National Committee for Quality Assurance (NCQA). The State of Healthcare, 2002: Comprehensive Diabetes Care. Available at: http://www.ncqa.org/somc2001/diabetes/somc_2001_cdiab.html. Accessed September 26, 2003.en_US
dc.identifier.citedreferenceSchneider EC, Riehl V, Courte-Wienecke S, Eddy DM, Sennett C. Enhancing performance measurement. NCQA's road map for a health information framework. JAMA. 1999; 282: 1184 – 90.en_US
dc.identifier.citedreferenceJones D, Hendricks A, Comstock C, et al. Eye examinations for VA patients with diabetes: standardizing performance measures. Int J Qual Health Care. 2000; 12: 97 – 104.en_US
dc.identifier.citedreferenceEddy DM. Performance measurement: problems and solutions. Health Aff. 1998; 17: 7 – 25.en_US
dc.identifier.citedreferenceKerr EA, Krein SL, Vijan S, Hofer TP, Hayward RA. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care. 2001; 7: 1033 – 43.en_US
dc.identifier.citedreferenceVijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000; 283: 889 – 96.en_US
dc.identifier.citedreferenceYounis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003; 361: 195 – 200.en_US
dc.identifier.citedreferenceKohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR. Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med. 2001; 18: 178 – 84.en_US
dc.identifier.citedreferenceStratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001; 44: 156 – 63.en_US
dc.identifier.citedreferenceKlein R. Screening interval for retinopathy in type 2 diabetes. Lancet. 2003; 361: 190 – 1.en_US
dc.identifier.citedreferenceFleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care. 2001; 24: 1815 – 20.en_US
dc.identifier.citedreference15.  American Diabetes Association/National Committee for Quality Assurance (ADA/NCQA). Diabetes Physician Recognition Program—DQIP Initial Measure Set. http://www.ncqa.org/dprp/dqip2.htm. Accessed September 26, 2003.en_US
dc.identifier.citedreferenceHayward RA, Hofer TP, Kerr EM, Krein SL. Quality improvement initiatives: issues in moving from diabetes guidelines to policy. Diabetes Care. 2004; 27 ( suppl 2 ): B54 – B60.en_US
dc.identifier.citedreferenceKrein SL, Hayward RA, Pogach L, BootsMiller BJ. Department of Veterans Affairs' quality enhancement research initiative for diabetes mellitus. Med Care. 2000; 38: I38 – I48.en_US
dc.identifier.citedreferenceHofer TP, Zemencuk JK, Hayward RA. When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med. 2004; 19: 646 – 53.en_US
dc.identifier.citedreference19.  National Committee for Quality Assurance (NCQA). HEDIS 2000: Health Plan Employer Data and Information Set. Washington, DC: National Committee for Quality Assurance; 1999.en_US
dc.identifier.citedreferenceKerr EA, Smith DM, Hogan MH, et al. Building a better quality measure: are some patients with “poor quality” actually getting good care? Med Care. 2003; 41: 1173 – 82.en_US
dc.identifier.citedreferenceStevens RJ, Stratton IM, Holman RR. UKPDS58—modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes. J Diabetes Complications. 2002; 16: 371 – 6.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1525-1497.2005.40073.x.pdf
Size:
73.38KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.